STOCK TITAN

Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference

(Moderate)
(Neutral)
Tags

Clover Health (Nasdaq: CLOV) announced that Interim Chief Financial Officer Clay Thornton will present at the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time. A live webcast and replay of the presentation and Q&A will be available on Clover Health’s investor relations website.

Clover Health describes itself as a physician enablement technology company focused on Medicare, offering PPO and HMO Medicare Advantage plans and extending its Clover Assistant platform via its subsidiary Counterpart Health.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

News Market Reaction – CLOV

-2.57%
1 alert
-2.57% Session close to close
$2.37B Market Cap
0.6x Rel. Volume

In the Jul 23 session, CLOV declined 2.57%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

Historical reactions included +5.22% for Q1 results and -1.19% for a Counterpart Health data release...
Analysis

Historical reactions included +5.22% for Q1 results and -1.19% for a Counterpart Health data release. That record frames this conference notice as an event without reported operating results; insider Net Selling is a risk factor to watch.

Key Figures

Conference edition: 46th annual Presentation date and time: August 11, 2026 at 8:30 a.m. Eastern Time
2 metrics
Conference edition 46th annual Canaccord Genuity Growth Conference
Presentation date and time August 11, 2026 at 8:30 a.m. Eastern Time Scheduled conference presentation

Historical Context

5 past events · Latest: Jul 09 (Neutral)
Pattern 5 events
Date Event Sentiment 24h Move Catalyst
Jul 09 Q2 results scheduling Neutral -5.1% Scheduled Q2 2026 results and webcast for August 5
Jul 07 Clinical data release Positive -1.2% Counterpart Assistant data showed improved transitions-of-care measures
May 06 Q1 earnings report Positive +5.2% Reported Q1 results with GAAP income, revenue, membership, and guidance
Apr 08 Q1 results scheduling Neutral -0.5% Scheduled Q1 2026 results and webcast for May 6
Apr 07 Data-sharing partnership Positive +1.6% Announced HealthEx partnership for member data access and sharing

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Historical reactions were mixed: positive operating or partnership news aligned twice, while other announcements diverged.

Key Terms

medicare advantage, ppo, hmo
3 terms
medicare advantage regulatory
"provide PPO and HMO Medicare Advantage plans in several states"
Medicare Advantage is a type of health insurance plan offered by private companies that covers services traditionally provided by government-run Medicare. Think of it as a bundled package that combines hospital, doctor, and other medical care into one plan, often with added benefits. For investors, it matters because the popularity and profitability of these plans can influence healthcare companies and the broader health insurance industry.
ppo financial
"provide PPO and HMO Medicare Advantage plans"
A PPO, or preferred provider organization, is a type of health insurance plan that gives members a network of doctors and hospitals who agree to lower fees, while still allowing patients to see providers outside the network at higher cost. Investors care because PPOs influence how medical services are paid for and used, affecting revenue and margins for insurers, hospitals, drug makers and companies that serve employer health plans—think of it as a merchant discount program that shapes who customers choose and what they pay.
hmo financial
"provide PPO and HMO Medicare Advantage plans"
HMO stands for Health Maintenance Organization, a type of managed health insurance plan that gives members access to a network of doctors and hospitals for a fixed premium and generally requires using in-network providers or referrals for specialists. Investors watch HMO performance because membership levels, cost controls and care network agreements directly affect revenue, profit margins and regulatory exposure—think of it as a subscription service that must balance member satisfaction with cost containment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WILMINGTON, Del., July 22, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, will present at the 2026 Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time.

A live webcast and replay of the presentation and Q&A session will be accessible on Clover Health's investor relations website at https://investors.cloverhealth.com/.

About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and in Underserved Populations as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.

Investor Relations:
Ryan Schmidt
investors@cloverhealth.com

Press Inquiries:
press@cloverhealth.com


FAQ

When will Clover Health (CLOV) present at the Canaccord Genuity 46th Annual Growth Conference in 2026?

Clover Health will present on Tuesday, August 11, 2026, at 8:30 a.m. Eastern Time. According to Clover Health, Interim CFO Clay Thornton will speak at the Canaccord Genuity 46th Annual Growth Conference as part of the event agenda.

Who will represent Clover Health (CLOV) at the 2026 Canaccord Genuity Growth Conference?

Interim Chief Financial Officer Clay Thornton will represent Clover Health at the conference. According to Clover Health, Thornton is scheduled to present and participate in a Q&A session during the 46th Annual Canaccord Genuity Growth Conference.

How can investors access the Clover Health (CLOV) presentation webcast from the Canaccord Genuity conference?

Investors can access a live webcast and replay on Clover Health’s investor relations website. According to Clover Health, the presentation and Q&A session will be streamed at https://investors.cloverhealth.com/ for convenient online viewing.

What does Clover Health (CLOV) describe as its core business focus in 2026?

Clover Health describes itself as a physician enablement technology company focused on Medicare. According to Clover Health, its Clover Assistant platform aggregates patient data to support clinical decision-making and improve outcomes, especially for seniors and underserved Medicare populations.

What Medicare Advantage products does Clover Health (CLOV) offer according to the July 22, 2026 update?

Clover Health offers PPO and HMO Medicare Advantage plans in several states. According to Clover Health, it emphasizes wide-network, high-choice PPO plans as its flagship product for Medicare members seeking flexibility in provider choice.